These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35057902)

  • 1. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017.
    Nuttens C; Findlow J; Balmer P; Swerdlow DL; Tin Tin Htar M
    Euro Surveill; 2022 Jan; 27(3):. PubMed ID: 35057902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review.
    Pardo de Santayana C; Tin Tin Htar M; Findlow J; Balmer P
    Epidemiol Infect; 2023 Mar; 151():e57. PubMed ID: 37052295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
    Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G
    Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018.
    Koliou M; Kasapi D; Mazeri S; Maikanti P; Demetriou A; Skordi C; Agathocleous M; Tzanakaki G; Constantinou E
    Euro Surveill; 2020 Jul; 25(30):. PubMed ID: 32734853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.
    Neri A; Pezzotti P; Fazio C; Vacca P; D'Ancona FP; Caporali MG; Stefanelli P
    PLoS One; 2015; 10(10):e0139376. PubMed ID: 26445461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014.
    Whittaker R; Dias JG; Ramliden M; Ködmön C; Economopoulou A; Beer N; Pastore Celentano L;
    Vaccine; 2017 Apr; 35(16):2034-2041. PubMed ID: 28314560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in Neisseria meningitidis infection in Italy after Meningococcal C conjugate vaccine introduction: A time trend analysis of 1994-2012 series.
    de Waure C; Miglietta A; Nedovic D; Mereu G; Ricciardi W
    Hum Vaccin Immunother; 2016; 12(2):467-73. PubMed ID: 26308192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.
    MacNeil JR; Blain AE; Wang X; Cohn AC
    Clin Infect Dis; 2018 Apr; 66(8):1276-1281. PubMed ID: 29126310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.
    Krone M; Gray S; Abad R; Skoczyńska A; Stefanelli P; van der Ende A; Tzanakaki G; Mölling P; João Simões M; Křížová P; Emonet S; Caugant DA; Toropainen M; Vazquez J; Waśko I; Knol MJ; Jacobsson S; Rodrigues Bettencourt C; Musilek M; Born R; Vogel U; Borrow R
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive meningococcal disease in the Veneto region of Italy: a capture-recapture analysis for assessing the effectiveness of an integrated surveillance system.
    Baldovin T; Lazzari R; Cocchio S; Furlan P; Bertoncello C; Saia M; Russo F; Baldo V
    BMJ Open; 2017 May; 7(4):e012478. PubMed ID: 28465304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of epidemiological and molecular data from invasive meningococcal disease surveillance in the Czech Republic, 1993-2020.
    Křížová P; Honskus M; Okonji Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2022; 71(3):148-160. PubMed ID: 36257794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.
    Booy R; Gentile A; Nissen M; Whelan J; Abitbol V
    Hum Vaccin Immunother; 2019; 15(2):470-480. PubMed ID: 30296197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia.
    Marshall HS; Lally N; Flood L; Phillips P
    Med J Aust; 2020 Feb; 212(2):89-93. PubMed ID: 31909501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
    Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.
    Bröker M; Emonet S; Fazio C; Jacobsson S; Koliou M; Kuusi M; Pace D; Paragi M; Pysik A; Simões MJ; Skoczynska A; Stefanelli P; Toropainen M; Taha MK; Tzanakaki G
    Hum Vaccin Immunother; 2015; 11(9):2281-6. PubMed ID: 26036710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.